1 | Targeting oncoproteins with a positive selection assay for protein degraders. (Koduri V, Duplaquet L, Lampson BL, Wang AC, Sabet AH, Ishoey M, Paulk J, Teng M, Harris IS, Endress JE, Liu X, Dasilva E, Paulo JA, Briggs KJ, Doench JG, Ott CJ, Zhang T, Donovan KA, Fischer ES, Gygi SP, Gray NS, Bradner J, Medin JA, Buhrlage SJ, Oser MG, Kaelin WG Jr) Sci Adv 2021 Feb;7(6) 21 Citations |
1 | Cul3 regulates cyclin E1 protein abundance via a degron located within the N-terminal region of cyclin E. (Davidge B, Rebola KGO, Agbor LN, Sigmund CD, Singer JD) J Cell Sci 2019 Nov 06;132(21) 11 Citations |
1 | Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. (Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H, Cancer Genome Atlas Research Network, Piwnica-Worms H, Ma L, Liang H) Cell Rep 2018 Apr 03;23(1):213-226.e3 71 Citations |
1 | DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. (Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, Koch AE, Fox DA, Engelke DR, Kaplan MJ, Markovitz DM) Nat Commun 2017 Feb 06;8:14252 73 Citations |
1 | Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastoma. (Lee S, Rellinger EJ, Kim KW, Craig BT, Romain CV, Qiao J, Chung DH) Surgery 2015 Sep;158(3):819-26 24 Citations |
1 | ULK3 regulates cytokinetic abscission by phosphorylating ESCRT-III proteins. (Caballe A, Wenzel DM, Agromayor M, Alam SL, Skalicky JJ, Kloc M, Carlton JG, Labrador L, Sundquist WI, Martin-Serrano J) Elife 2015 May 26;4:e06547 67 Citations |
1 | Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation. (Lee S, Craig BT, Romain CV, Qiao J, Chung DH) Cancer Lett 2014 Dec 28;355(2):210-6 21 Citations |
1 | NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis. (Xue L, Pulikkan JA, Valk PJ, Castilla LH) Blood 2014 Jul 17;124(3):426-36 22 Citations |
1 | Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. (Chen W, Ayala-Orozco C, Biswal NC, Perez-Torres C, Bartels M, Bardhan R, Stinnet G, Liu XD, Ji B, Deorukhkar A, Brown LV, Guha S, Pautler RG, Krishnan S, Halas NJ, Joshi A) Nanomedicine (Lond) 2014;9(8):1209-22 60 Citations |
1 | Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. (Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, Lance RS, Gramolini AO, Troyer DA, Stein LD, Boutros PC, Medin JA, Semmes OJ, Drake RR, Kislinger T) Mol Cell Proteomics 2012 Dec;11(12):1870-84 73 Citations |
1 | Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee. (Suganuma R, Wang LL, Sano H, Naranjo A, London WB, Seeger RC, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Jarzembowski JA, Joshi VV, Navarro S, Peuchmaur M, Shimada H) Pediatr Blood Cancer 2013 Mar;60(3):363-70 27 Citations |
1 | Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. (Rizvi S, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernández-Zapico ME, Buttar NS) Cancer Res 2010 Sep 01;70(17):6787-96 41 Citations |
1 | Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen. (Zheng J, Kohler ME, Chen Q, Weber J, Khan J, Johnson BD, Orentas RJ) BMC Immunol 2007 Mar 30;8:4 11 Citations |
1 | ErbB receptor signaling and therapeutic resistance to aromatase inhibitors. (Shin I, Miller T, Arteaga CL) Clin Cancer Res 2006 Feb 01;12(3 Pt 2):1008s-1012s 40 Citations |
1 | Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. (Hanai J, Mammoto T, Seth P, Mori K, Karumanchi SA, Barasch J, Sukhatme VP) J Biol Chem 2005 Apr 08;280(14):13641-7 110 Citations |
1 | COMBO-FISH: specific labeling of nondenatured chromatin targets by computer-selected DNA oligonucleotide probe combinations. (Hausmann M, Winkler R, Hildenbrand G, Finsterle J, Weisel A, Rapp A, Schmitt E, Janz S, Cremer C) Biotechniques 2003 Sep;35(3):564-70, 572-7 47 Citations |
1 | CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth. (Strock CJ, Park JI, Rosen M, Dionne C, Ruggeri B, Jones-Bolin S, Denmeade SR, Ball DW, Nelkin BD) Cancer Res 2003 Sep 01;63(17):5559-63 91 Citations |
1 | Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. (Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB) Arch Surg 2003 Apr;138(4):409-16; discussion 416 191 Citations |
1 | BCR rearrangement-negative chronic myelogenous leukemia revisited. (Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M, Pilat S, Talpaz M) J Clin Oncol 2001 Jun 01;19(11):2915-26 88 Citations |
1 | The BCR gene and philadelphia chromosome-positive leukemogenesis. (Laurent E, Talpaz M, Kantarjian H, Kurzrock R) Cancer Res 2001 Mar 15;61(6):2343-55 116 Citations |
1 | Autoantibodies to Abl and Bcr proteins. (Talpaz M, Qiu X, Cheng K, Cortes JE, Kantarjian H, Kurzrock R) Leukemia 2000 Sep;14(9):1661-6 3 Citations |
1 | The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. (Lu J, Chang P, Richardson JA, Gan L, Weiler H, Olson EN) Proc Natl Acad Sci U S A 2000 Aug 15;97(17):9525-30 111 Citations |
1 | KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. (Andersson BS, Collins VP, Kurzrock R, Larkin DW, Childs C, Ost A, Cork A, Trujillo JM, Freireich EJ, Siciliano MJ) Leukemia 1995 Dec;9(12):2100-8 |
1 | Cell cycle-related shifts in subcellular localization of BCR: association with mitotic chromosomes and with heterochromatin. (Wetzler M, Talpaz M, Yee G, Stass SA, Van Etten RA, Andreeff M, Goodacre AM, Kleine HD, Mahadevia RK, Kurzrock R) Proc Natl Acad Sci U S A 1995 Apr 11;92(8):3488-92 22 Citations |
1 | Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. (Kurzrock R, Ku S, Talpaz M) Cancer 1995 Jan 15;75(2):584-90 57 Citations |
1 | Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. (Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R) J Clin Invest 1994 Oct;94(4):1383-9 98 Citations |